A. Spanevello (Tradate, Italy), I. Pavord (Leicester, United Kingdom)
Longitudinal analysis of lung function decline with eosinophilic clustering in severe asthma
C. Newby, J. Agbetile, B. Hargadon, P. Bradding, A. Wardlaw, I. Pavord, R. Green, C. Brighling, S. Siddiqui (Leicester, United Kingdom)
|   |
Sputum eosinophilia identifies systemic corticosteroid responsiveness in acute exacerbations of COPD
M. Bafadhel, S. McKenna, S. Terry, V. Mistry, M. Pancholi, D. Lomas, P. Venge, M. Barer, S. Johnston, I. Pavord, C. Brightling (Leicester, London, Cambridge, United Kingdom; Uppsala, Sweden)
| |
Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide
S. Hashimoto, A. Ten Brinke, J. K. Sont, A. H. Zwinderman, P. J. Sterk, E. H. Bel (Amsterdam, Leeuwarden, Leiden, Netherlands)
| |
Sputum eosinophil levels in corticosteroid-treated asthmatic patients
E. Bacci, M. Latorre, S. Cianchetti, F. Dente, A. Di Franco, L. Melosini, F. Novelli, E. Camici, P. Paggiaro (Pisa, Italy)
| |
A double-blind randomised control trial of peripheral blood eosinophils to direct prednisolone use in COPD exacerbations
M. Bafadhel, S. McKenna, S. Terry, V. Mistry, M. Pancholi, D. Lomas, P. Venge, M. Barer, S. Johnston, I. Pavord, C. Brightling (Leicester, London, Cambridge, United Kingdom; Uppsala, Sweden)
| |
Relationship between exhaled nitric oxide and exacerbation frequency in COPD patients: A longitudinal study
B. Antus, S. Soter, I. Barta (Budapest, Hungary)
| |
Expression of superoxide dismutases and its association to inflammatory cells in small airways of COPD patients
B. T. Olejnicka, S. Marklund, C. Andersson, M. Mori, A. Rubaj, C. G. Löfdahl, J. Erjefält (Lund, Umeå, Sweden; Lublin, Poland)
| |
Disease expression in patients with primary ciliary dyskinesia (PCD), CF and pancreatic sufficiency (CF-PS) and insufficiency (CF-PI)
M. Cohen-Cymberknoh, N. Simanovski, N. Hiller, A. Gileles Hillel, D. Shoseyov, E. Kerem (Jerusalem, Israel)
| |